If we have the relevant contacts, we will be happy to share.
GHK-Cu (glycine-L-histidine-lysine) is a small copper-binding peptide, which has a remarkable and well-documented ability to improve wound healing and tissue regeneration, regulate remodeling of connective tissue and synthesis of collagen, elastin and glycosaminoglycans, reduce inflammation and scarring, increase antioxidant-enzymes and protect cells from toxic by-products of lipid peroxidation
In Elena's case, DripGym's evaluation confirmed she was a reasonable candidate for a systemic protocol with specific aesthetic goals, skin quality and connective tissue support, alongside realistic expectations about what injectable GHK-Cu could and couldn't do relative to the topical evidence she'd read
Combining these profiles introduces unpredictable interaction risks that have not been characterised in any clinical setting
Testing is warranted when one or more of the following apply: Significant appetite loss lasting more than 3 months on stimulant therapy Concurrent metformin use Vegetarian or vegan diet Age over 50 (gastric acid and intrinsic factor production decline) History of gastric surgery, celiac disease, or Crohn disease affecting the terminal ileum New-onset fatigue, paresthesias, or cognitive complaints that do not match ADHD symptom patterns Which Labs to Order Serum B12 alone has limited sensitivity
(2020) showed that encapsulation of probiotics can improve fish survival and reduce stress
